0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Sickle Cell Disease Diagnosis and Treatment Market Research Report 2024
Published Date: May 2024
|
Report Code: QYRE-Auto-18M13082
Home | Market Reports | Health| Health Conditions| Genetic Disorders
Global Sickle Cell Disease Diagnosis and Treatment Market Research Report 2023
BUY CHAPTERS

Global Sickle Cell Disease Diagnosis and Treatment Market Research Report 2024

Code: QYRE-Auto-18M13082
Report
May 2024
Pages:91
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Sickle Cell Disease Diagnosis and Treatment Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Sickle Cell Disease Diagnosis and Treatment Market

Sickle Cell Disease Diagnosis and Treatment Market

The global Sickle Cell Disease Diagnosis and Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Sickle Cell Disease Diagnosis and Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sickle Cell Disease Diagnosis and Treatment.

Report Scope

The Sickle Cell Disease Diagnosis and Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Sickle Cell Disease Diagnosis and Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sickle Cell Disease Diagnosis and Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Sickle Cell Disease Diagnosis and Treatment Market Report

Report Metric Details
Report Name Sickle Cell Disease Diagnosis and Treatment Market
CAGR 5%
Segment by Type
  • Diagnosis
  • Treatment
Segment by Application
  • Child
  • Adult
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Emmaus Medical, Addmedica, Gamida Cell, GlycoMimetics, Pfizer, Novartis, Global Blood Therapeutics, Micelle BioPharma, Bluebird Bio, Prolong Pharmaceuticals, Modus Therapeutics, Sangamo Biosciences, Bioverativ, Imara, Ironwood Pharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Sickle Cell Disease Diagnosis and Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Sickle Cell Disease Diagnosis and Treatment Market report?

Ans: The main players in the Sickle Cell Disease Diagnosis and Treatment Market are Emmaus Medical, Addmedica, Gamida Cell, GlycoMimetics, Pfizer, Novartis, Global Blood Therapeutics, Micelle BioPharma, Bluebird Bio, Prolong Pharmaceuticals, Modus Therapeutics, Sangamo Biosciences, Bioverativ, Imara, Ironwood Pharmaceuticals

What are the Application segmentation covered in the Sickle Cell Disease Diagnosis and Treatment Market report?

Ans: The Applications covered in the Sickle Cell Disease Diagnosis and Treatment Market report are Child, Adult

What are the Type segmentation covered in the Sickle Cell Disease Diagnosis and Treatment Market report?

Ans: The Types covered in the Sickle Cell Disease Diagnosis and Treatment Market report are Diagnosis, Treatment

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Sickle Cell Disease Diagnosis and Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Diagnosis
1.2.3 Treatment
1.3 Market by Application
1.3.1 Global Sickle Cell Disease Diagnosis and Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Child
1.3.3 Adult
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Sickle Cell Disease Diagnosis and Treatment Market Perspective (2019-2030)
2.2 Sickle Cell Disease Diagnosis and Treatment Growth Trends by Region
2.2.1 Global Sickle Cell Disease Diagnosis and Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Sickle Cell Disease Diagnosis and Treatment Historic Market Size by Region (2019-2024)
2.2.3 Sickle Cell Disease Diagnosis and Treatment Forecasted Market Size by Region (2025-2030)
2.3 Sickle Cell Disease Diagnosis and Treatment Market Dynamics
2.3.1 Sickle Cell Disease Diagnosis and Treatment Industry Trends
2.3.2 Sickle Cell Disease Diagnosis and Treatment Market Drivers
2.3.3 Sickle Cell Disease Diagnosis and Treatment Market Challenges
2.3.4 Sickle Cell Disease Diagnosis and Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Sickle Cell Disease Diagnosis and Treatment Players by Revenue
3.1.1 Global Top Sickle Cell Disease Diagnosis and Treatment Players by Revenue (2019-2024)
3.1.2 Global Sickle Cell Disease Diagnosis and Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Sickle Cell Disease Diagnosis and Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Sickle Cell Disease Diagnosis and Treatment Revenue
3.4 Global Sickle Cell Disease Diagnosis and Treatment Market Concentration Ratio
3.4.1 Global Sickle Cell Disease Diagnosis and Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Sickle Cell Disease Diagnosis and Treatment Revenue in 2023
3.5 Sickle Cell Disease Diagnosis and Treatment Key Players Head office and Area Served
3.6 Key Players Sickle Cell Disease Diagnosis and Treatment Product Solution and Service
3.7 Date of Enter into Sickle Cell Disease Diagnosis and Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Sickle Cell Disease Diagnosis and Treatment Breakdown Data by Type
4.1 Global Sickle Cell Disease Diagnosis and Treatment Historic Market Size by Type (2019-2024)
4.2 Global Sickle Cell Disease Diagnosis and Treatment Forecasted Market Size by Type (2025-2030)
5 Sickle Cell Disease Diagnosis and Treatment Breakdown Data by Application
5.1 Global Sickle Cell Disease Diagnosis and Treatment Historic Market Size by Application (2019-2024)
5.2 Global Sickle Cell Disease Diagnosis and Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Sickle Cell Disease Diagnosis and Treatment Market Size (2019-2030)
6.2 North America Sickle Cell Disease Diagnosis and Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Sickle Cell Disease Diagnosis and Treatment Market Size by Country (2019-2024)
6.4 North America Sickle Cell Disease Diagnosis and Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Sickle Cell Disease Diagnosis and Treatment Market Size (2019-2030)
7.2 Europe Sickle Cell Disease Diagnosis and Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Sickle Cell Disease Diagnosis and Treatment Market Size by Country (2019-2024)
7.4 Europe Sickle Cell Disease Diagnosis and Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Sickle Cell Disease Diagnosis and Treatment Market Size (2019-2030)
8.2 Asia-Pacific Sickle Cell Disease Diagnosis and Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Sickle Cell Disease Diagnosis and Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific Sickle Cell Disease Diagnosis and Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Sickle Cell Disease Diagnosis and Treatment Market Size (2019-2030)
9.2 Latin America Sickle Cell Disease Diagnosis and Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Sickle Cell Disease Diagnosis and Treatment Market Size by Country (2019-2024)
9.4 Latin America Sickle Cell Disease Diagnosis and Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Sickle Cell Disease Diagnosis and Treatment Market Size (2019-2030)
10.2 Middle East & Africa Sickle Cell Disease Diagnosis and Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Sickle Cell Disease Diagnosis and Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa Sickle Cell Disease Diagnosis and Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Emmaus Medical
11.1.1 Emmaus Medical Company Detail
11.1.2 Emmaus Medical Business Overview
11.1.3 Emmaus Medical Sickle Cell Disease Diagnosis and Treatment Introduction
11.1.4 Emmaus Medical Revenue in Sickle Cell Disease Diagnosis and Treatment Business (2019-2024)
11.1.5 Emmaus Medical Recent Development
11.2 Addmedica
11.2.1 Addmedica Company Detail
11.2.2 Addmedica Business Overview
11.2.3 Addmedica Sickle Cell Disease Diagnosis and Treatment Introduction
11.2.4 Addmedica Revenue in Sickle Cell Disease Diagnosis and Treatment Business (2019-2024)
11.2.5 Addmedica Recent Development
11.3 Gamida Cell
11.3.1 Gamida Cell Company Detail
11.3.2 Gamida Cell Business Overview
11.3.3 Gamida Cell Sickle Cell Disease Diagnosis and Treatment Introduction
11.3.4 Gamida Cell Revenue in Sickle Cell Disease Diagnosis and Treatment Business (2019-2024)
11.3.5 Gamida Cell Recent Development
11.4 GlycoMimetics
11.4.1 GlycoMimetics Company Detail
11.4.2 GlycoMimetics Business Overview
11.4.3 GlycoMimetics Sickle Cell Disease Diagnosis and Treatment Introduction
11.4.4 GlycoMimetics Revenue in Sickle Cell Disease Diagnosis and Treatment Business (2019-2024)
11.4.5 GlycoMimetics Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Detail
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Sickle Cell Disease Diagnosis and Treatment Introduction
11.5.4 Pfizer Revenue in Sickle Cell Disease Diagnosis and Treatment Business (2019-2024)
11.5.5 Pfizer Recent Development
11.6 Novartis
11.6.1 Novartis Company Detail
11.6.2 Novartis Business Overview
11.6.3 Novartis Sickle Cell Disease Diagnosis and Treatment Introduction
11.6.4 Novartis Revenue in Sickle Cell Disease Diagnosis and Treatment Business (2019-2024)
11.6.5 Novartis Recent Development
11.7 Global Blood Therapeutics
11.7.1 Global Blood Therapeutics Company Detail
11.7.2 Global Blood Therapeutics Business Overview
11.7.3 Global Blood Therapeutics Sickle Cell Disease Diagnosis and Treatment Introduction
11.7.4 Global Blood Therapeutics Revenue in Sickle Cell Disease Diagnosis and Treatment Business (2019-2024)
11.7.5 Global Blood Therapeutics Recent Development
11.8 Micelle BioPharma
11.8.1 Micelle BioPharma Company Detail
11.8.2 Micelle BioPharma Business Overview
11.8.3 Micelle BioPharma Sickle Cell Disease Diagnosis and Treatment Introduction
11.8.4 Micelle BioPharma Revenue in Sickle Cell Disease Diagnosis and Treatment Business (2019-2024)
11.8.5 Micelle BioPharma Recent Development
11.9 Bluebird Bio
11.9.1 Bluebird Bio Company Detail
11.9.2 Bluebird Bio Business Overview
11.9.3 Bluebird Bio Sickle Cell Disease Diagnosis and Treatment Introduction
11.9.4 Bluebird Bio Revenue in Sickle Cell Disease Diagnosis and Treatment Business (2019-2024)
11.9.5 Bluebird Bio Recent Development
11.10 Prolong Pharmaceuticals
11.10.1 Prolong Pharmaceuticals Company Detail
11.10.2 Prolong Pharmaceuticals Business Overview
11.10.3 Prolong Pharmaceuticals Sickle Cell Disease Diagnosis and Treatment Introduction
11.10.4 Prolong Pharmaceuticals Revenue in Sickle Cell Disease Diagnosis and Treatment Business (2019-2024)
11.10.5 Prolong Pharmaceuticals Recent Development
11.11 Modus Therapeutics
11.11.1 Modus Therapeutics Company Detail
11.11.2 Modus Therapeutics Business Overview
11.11.3 Modus Therapeutics Sickle Cell Disease Diagnosis and Treatment Introduction
11.11.4 Modus Therapeutics Revenue in Sickle Cell Disease Diagnosis and Treatment Business (2019-2024)
11.11.5 Modus Therapeutics Recent Development
11.12 Sangamo Biosciences
11.12.1 Sangamo Biosciences Company Detail
11.12.2 Sangamo Biosciences Business Overview
11.12.3 Sangamo Biosciences Sickle Cell Disease Diagnosis and Treatment Introduction
11.12.4 Sangamo Biosciences Revenue in Sickle Cell Disease Diagnosis and Treatment Business (2019-2024)
11.12.5 Sangamo Biosciences Recent Development
11.13 Bioverativ
11.13.1 Bioverativ Company Detail
11.13.2 Bioverativ Business Overview
11.13.3 Bioverativ Sickle Cell Disease Diagnosis and Treatment Introduction
11.13.4 Bioverativ Revenue in Sickle Cell Disease Diagnosis and Treatment Business (2019-2024)
11.13.5 Bioverativ Recent Development
11.14 Imara
11.14.1 Imara Company Detail
11.14.2 Imara Business Overview
11.14.3 Imara Sickle Cell Disease Diagnosis and Treatment Introduction
11.14.4 Imara Revenue in Sickle Cell Disease Diagnosis and Treatment Business (2019-2024)
11.14.5 Imara Recent Development
11.15 Ironwood Pharmaceuticals
11.15.1 Ironwood Pharmaceuticals Company Detail
11.15.2 Ironwood Pharmaceuticals Business Overview
11.15.3 Ironwood Pharmaceuticals Sickle Cell Disease Diagnosis and Treatment Introduction
11.15.4 Ironwood Pharmaceuticals Revenue in Sickle Cell Disease Diagnosis and Treatment Business (2019-2024)
11.15.5 Ironwood Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Sickle Cell Disease Diagnosis and Treatment Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
    Table 2. Key Players of Diagnosis
    Table 3. Key Players of Treatment
    Table 4. Global Sickle Cell Disease Diagnosis and Treatment Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
    Table 5. Global Sickle Cell Disease Diagnosis and Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 6. Global Sickle Cell Disease Diagnosis and Treatment Market Size by Region (2019-2024) & (US$ Million)
    Table 7. Global Sickle Cell Disease Diagnosis and Treatment Market Share by Region (2019-2024)
    Table 8. Global Sickle Cell Disease Diagnosis and Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 9. Global Sickle Cell Disease Diagnosis and Treatment Market Share by Region (2025-2030)
    Table 10. Sickle Cell Disease Diagnosis and Treatment Market Trends
    Table 11. Sickle Cell Disease Diagnosis and Treatment Market Drivers
    Table 12. Sickle Cell Disease Diagnosis and Treatment Market Challenges
    Table 13. Sickle Cell Disease Diagnosis and Treatment Market Restraints
    Table 14. Global Sickle Cell Disease Diagnosis and Treatment Revenue by Players (2019-2024) & (US$ Million)
    Table 15. Global Sickle Cell Disease Diagnosis and Treatment Market Share by Players (2019-2024)
    Table 16. Global Top Sickle Cell Disease Diagnosis and Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sickle Cell Disease Diagnosis and Treatment as of 2023)
    Table 17. Ranking of Global Top Sickle Cell Disease Diagnosis and Treatment Companies by Revenue (US$ Million) in 2023
    Table 18. Global 5 Largest Players Market Share by Sickle Cell Disease Diagnosis and Treatment Revenue (CR5 and HHI) & (2019-2024)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Sickle Cell Disease Diagnosis and Treatment Product Solution and Service
    Table 21. Date of Enter into Sickle Cell Disease Diagnosis and Treatment Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Sickle Cell Disease Diagnosis and Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 24. Global Sickle Cell Disease Diagnosis and Treatment Revenue Market Share by Type (2019-2024)
    Table 25. Global Sickle Cell Disease Diagnosis and Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 26. Global Sickle Cell Disease Diagnosis and Treatment Revenue Market Share by Type (2025-2030)
    Table 27. Global Sickle Cell Disease Diagnosis and Treatment Market Size by Application (2019-2024) & (US$ Million)
    Table 28. Global Sickle Cell Disease Diagnosis and Treatment Revenue Market Share by Application (2019-2024)
    Table 29. Global Sickle Cell Disease Diagnosis and Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 30. Global Sickle Cell Disease Diagnosis and Treatment Revenue Market Share by Application (2025-2030)
    Table 31. North America Sickle Cell Disease Diagnosis and Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 32. North America Sickle Cell Disease Diagnosis and Treatment Market Size by Country (2019-2024) & (US$ Million)
    Table 33. North America Sickle Cell Disease Diagnosis and Treatment Market Size by Country (2025-2030) & (US$ Million)
    Table 34. Europe Sickle Cell Disease Diagnosis and Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 35. Europe Sickle Cell Disease Diagnosis and Treatment Market Size by Country (2019-2024) & (US$ Million)
    Table 36. Europe Sickle Cell Disease Diagnosis and Treatment Market Size by Country (2025-2030) & (US$ Million)
    Table 37. Asia-Pacific Sickle Cell Disease Diagnosis and Treatment Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 38. Asia-Pacific Sickle Cell Disease Diagnosis and Treatment Market Size by Region (2019-2024) & (US$ Million)
    Table 39. Asia-Pacific Sickle Cell Disease Diagnosis and Treatment Market Size by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Sickle Cell Disease Diagnosis and Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 41. Latin America Sickle Cell Disease Diagnosis and Treatment Market Size by Country (2019-2024) & (US$ Million)
    Table 42. Latin America Sickle Cell Disease Diagnosis and Treatment Market Size by Country (2025-2030) & (US$ Million)
    Table 43. Middle East & Africa Sickle Cell Disease Diagnosis and Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 44. Middle East & Africa Sickle Cell Disease Diagnosis and Treatment Market Size by Country (2019-2024) & (US$ Million)
    Table 45. Middle East & Africa Sickle Cell Disease Diagnosis and Treatment Market Size by Country (2025-2030) & (US$ Million)
    Table 46. Emmaus Medical Company Detail
    Table 47. Emmaus Medical Business Overview
    Table 48. Emmaus Medical Sickle Cell Disease Diagnosis and Treatment Product
    Table 49. Emmaus Medical Revenue in Sickle Cell Disease Diagnosis and Treatment Business (2019-2024) & (US$ Million)
    Table 50. Emmaus Medical Recent Development
    Table 51. Addmedica Company Detail
    Table 52. Addmedica Business Overview
    Table 53. Addmedica Sickle Cell Disease Diagnosis and Treatment Product
    Table 54. Addmedica Revenue in Sickle Cell Disease Diagnosis and Treatment Business (2019-2024) & (US$ Million)
    Table 55. Addmedica Recent Development
    Table 56. Gamida Cell Company Detail
    Table 57. Gamida Cell Business Overview
    Table 58. Gamida Cell Sickle Cell Disease Diagnosis and Treatment Product
    Table 59. Gamida Cell Revenue in Sickle Cell Disease Diagnosis and Treatment Business (2019-2024) & (US$ Million)
    Table 60. Gamida Cell Recent Development
    Table 61. GlycoMimetics Company Detail
    Table 62. GlycoMimetics Business Overview
    Table 63. GlycoMimetics Sickle Cell Disease Diagnosis and Treatment Product
    Table 64. GlycoMimetics Revenue in Sickle Cell Disease Diagnosis and Treatment Business (2019-2024) & (US$ Million)
    Table 65. GlycoMimetics Recent Development
    Table 66. Pfizer Company Detail
    Table 67. Pfizer Business Overview
    Table 68. Pfizer Sickle Cell Disease Diagnosis and Treatment Product
    Table 69. Pfizer Revenue in Sickle Cell Disease Diagnosis and Treatment Business (2019-2024) & (US$ Million)
    Table 70. Pfizer Recent Development
    Table 71. Novartis Company Detail
    Table 72. Novartis Business Overview
    Table 73. Novartis Sickle Cell Disease Diagnosis and Treatment Product
    Table 74. Novartis Revenue in Sickle Cell Disease Diagnosis and Treatment Business (2019-2024) & (US$ Million)
    Table 75. Novartis Recent Development
    Table 76. Global Blood Therapeutics Company Detail
    Table 77. Global Blood Therapeutics Business Overview
    Table 78. Global Blood Therapeutics Sickle Cell Disease Diagnosis and Treatment Product
    Table 79. Global Blood Therapeutics Revenue in Sickle Cell Disease Diagnosis and Treatment Business (2019-2024) & (US$ Million)
    Table 80. Global Blood Therapeutics Recent Development
    Table 81. Micelle BioPharma Company Detail
    Table 82. Micelle BioPharma Business Overview
    Table 83. Micelle BioPharma Sickle Cell Disease Diagnosis and Treatment Product
    Table 84. Micelle BioPharma Revenue in Sickle Cell Disease Diagnosis and Treatment Business (2019-2024) & (US$ Million)
    Table 85. Micelle BioPharma Recent Development
    Table 86. Bluebird Bio Company Detail
    Table 87. Bluebird Bio Business Overview
    Table 88. Bluebird Bio Sickle Cell Disease Diagnosis and Treatment Product
    Table 89. Bluebird Bio Revenue in Sickle Cell Disease Diagnosis and Treatment Business (2019-2024) & (US$ Million)
    Table 90. Bluebird Bio Recent Development
    Table 91. Prolong Pharmaceuticals Company Detail
    Table 92. Prolong Pharmaceuticals Business Overview
    Table 93. Prolong Pharmaceuticals Sickle Cell Disease Diagnosis and Treatment Product
    Table 94. Prolong Pharmaceuticals Revenue in Sickle Cell Disease Diagnosis and Treatment Business (2019-2024) & (US$ Million)
    Table 95. Prolong Pharmaceuticals Recent Development
    Table 96. Modus Therapeutics Company Detail
    Table 97. Modus Therapeutics Business Overview
    Table 98. Modus Therapeutics Sickle Cell Disease Diagnosis and Treatment Product
    Table 99. Modus Therapeutics Revenue in Sickle Cell Disease Diagnosis and Treatment Business (2019-2024) & (US$ Million)
    Table 100. Modus Therapeutics Recent Development
    Table 101. Sangamo Biosciences Company Detail
    Table 102. Sangamo Biosciences Business Overview
    Table 103. Sangamo Biosciences Sickle Cell Disease Diagnosis and Treatment Product
    Table 104. Sangamo Biosciences Revenue in Sickle Cell Disease Diagnosis and Treatment Business (2019-2024) & (US$ Million)
    Table 105. Sangamo Biosciences Recent Development
    Table 106. Bioverativ Company Detail
    Table 107. Bioverativ Business Overview
    Table 108. Bioverativ Sickle Cell Disease Diagnosis and Treatment Product
    Table 109. Bioverativ Revenue in Sickle Cell Disease Diagnosis and Treatment Business (2019-2024) & (US$ Million)
    Table 110. Bioverativ Recent Development
    Table 111. Imara Company Detail
    Table 112. Imara Business Overview
    Table 113. Imara Sickle Cell Disease Diagnosis and Treatment Product
    Table 114. Imara Revenue in Sickle Cell Disease Diagnosis and Treatment Business (2019-2024) & (US$ Million)
    Table 115. Imara Recent Development
    Table 116. Ironwood Pharmaceuticals Company Detail
    Table 117. Ironwood Pharmaceuticals Business Overview
    Table 118. Ironwood Pharmaceuticals Sickle Cell Disease Diagnosis and Treatment Product
    Table 119. Ironwood Pharmaceuticals Revenue in Sickle Cell Disease Diagnosis and Treatment Business (2019-2024) & (US$ Million)
    Table 120. Ironwood Pharmaceuticals Recent Development
    Table 121. Research Programs/Design for This Report
    Table 122. Key Data Information from Secondary Sources
    Table 123. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Sickle Cell Disease Diagnosis and Treatment Market Size Comparison by Type (2024-2030) & (US$ Million)
    Figure 2. Global Sickle Cell Disease Diagnosis and Treatment Market Share by Type: 2023 VS 2030
    Figure 3. Diagnosis Features
    Figure 4. Treatment Features
    Figure 5. Global Sickle Cell Disease Diagnosis and Treatment Market Size Comparison by Application (2024-2030) & (US$ Million)
    Figure 6. Global Sickle Cell Disease Diagnosis and Treatment Market Share by Application: 2023 VS 2030
    Figure 7. Child Case Studies
    Figure 8. Adult Case Studies
    Figure 9. Sickle Cell Disease Diagnosis and Treatment Report Years Considered
    Figure 10. Global Sickle Cell Disease Diagnosis and Treatment Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 11. Global Sickle Cell Disease Diagnosis and Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 12. Global Sickle Cell Disease Diagnosis and Treatment Market Share by Region: 2023 VS 2030
    Figure 13. Global Sickle Cell Disease Diagnosis and Treatment Market Share by Players in 2023
    Figure 14. Global Top Sickle Cell Disease Diagnosis and Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sickle Cell Disease Diagnosis and Treatment as of 2023)
    Figure 15. The Top 10 and 5 Players Market Share by Sickle Cell Disease Diagnosis and Treatment Revenue in 2023
    Figure 16. North America Sickle Cell Disease Diagnosis and Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 17. North America Sickle Cell Disease Diagnosis and Treatment Market Share by Country (2019-2030)
    Figure 18. United States Sickle Cell Disease Diagnosis and Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 19. Canada Sickle Cell Disease Diagnosis and Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 20. Europe Sickle Cell Disease Diagnosis and Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 21. Europe Sickle Cell Disease Diagnosis and Treatment Market Share by Country (2019-2030)
    Figure 22. Germany Sickle Cell Disease Diagnosis and Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. France Sickle Cell Disease Diagnosis and Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. U.K. Sickle Cell Disease Diagnosis and Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. Italy Sickle Cell Disease Diagnosis and Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 26. Russia Sickle Cell Disease Diagnosis and Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 27. Nordic Countries Sickle Cell Disease Diagnosis and Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. Asia-Pacific Sickle Cell Disease Diagnosis and Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. Asia-Pacific Sickle Cell Disease Diagnosis and Treatment Market Share by Region (2019-2030)
    Figure 30. China Sickle Cell Disease Diagnosis and Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Japan Sickle Cell Disease Diagnosis and Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. South Korea Sickle Cell Disease Diagnosis and Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Southeast Asia Sickle Cell Disease Diagnosis and Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. India Sickle Cell Disease Diagnosis and Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. Australia Sickle Cell Disease Diagnosis and Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. Latin America Sickle Cell Disease Diagnosis and Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. Latin America Sickle Cell Disease Diagnosis and Treatment Market Share by Country (2019-2030)
    Figure 38. Mexico Sickle Cell Disease Diagnosis and Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 39. Brazil Sickle Cell Disease Diagnosis and Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 40. Middle East & Africa Sickle Cell Disease Diagnosis and Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 41. Middle East & Africa Sickle Cell Disease Diagnosis and Treatment Market Share by Country (2019-2030)
    Figure 42. Turkey Sickle Cell Disease Diagnosis and Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. Saudi Arabia Sickle Cell Disease Diagnosis and Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. Emmaus Medical Revenue Growth Rate in Sickle Cell Disease Diagnosis and Treatment Business (2019-2024)
    Figure 45. Addmedica Revenue Growth Rate in Sickle Cell Disease Diagnosis and Treatment Business (2019-2024)
    Figure 46. Gamida Cell Revenue Growth Rate in Sickle Cell Disease Diagnosis and Treatment Business (2019-2024)
    Figure 47. GlycoMimetics Revenue Growth Rate in Sickle Cell Disease Diagnosis and Treatment Business (2019-2024)
    Figure 48. Pfizer Revenue Growth Rate in Sickle Cell Disease Diagnosis and Treatment Business (2019-2024)
    Figure 49. Novartis Revenue Growth Rate in Sickle Cell Disease Diagnosis and Treatment Business (2019-2024)
    Figure 50. Global Blood Therapeutics Revenue Growth Rate in Sickle Cell Disease Diagnosis and Treatment Business (2019-2024)
    Figure 51. Micelle BioPharma Revenue Growth Rate in Sickle Cell Disease Diagnosis and Treatment Business (2019-2024)
    Figure 52. Bluebird Bio Revenue Growth Rate in Sickle Cell Disease Diagnosis and Treatment Business (2019-2024)
    Figure 53. Prolong Pharmaceuticals Revenue Growth Rate in Sickle Cell Disease Diagnosis and Treatment Business (2019-2024)
    Figure 54. Modus Therapeutics Revenue Growth Rate in Sickle Cell Disease Diagnosis and Treatment Business (2019-2024)
    Figure 55. Sangamo Biosciences Revenue Growth Rate in Sickle Cell Disease Diagnosis and Treatment Business (2019-2024)
    Figure 56. Bioverativ Revenue Growth Rate in Sickle Cell Disease Diagnosis and Treatment Business (2019-2024)
    Figure 57. Imara Revenue Growth Rate in Sickle Cell Disease Diagnosis and Treatment Business (2019-2024)
    Figure 58. Ironwood Pharmaceuticals Revenue Growth Rate in Sickle Cell Disease Diagnosis and Treatment Business (2019-2024)
    Figure 59. Bottom-up and Top-down Approaches for This Report
    Figure 60. Data Triangulation
    Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture

SIMILAR REPORTS